Mesenchymal stem cells (MSCs) possess immunomodulatory properties that are essential for the development of regenerative therapies. In MSC culture, serum selection is critical because fetal bovine serum (FBS) carries a risk of xenogeneic immunization, making human platelet lysate (HPL) a more biocompatible alternative. This study aimed to analyze the differences in the expression of the Interle…